New York 2025-2026 Regular Session

New York Assembly Bill A00265

Introduced
1/8/25  
Refer
1/8/25  
Report Pass
2/11/25  
Refer
2/11/25  
Report Pass
6/13/25  
Refer
6/13/25  
Report Pass
6/13/25  

Caption

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Companion Bills

NY S04150

Same As Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.

Previously Filed As

NY S08991

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.

NY A08075

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

NY A09595

Requires the availability and permits the use of opioid antagonists on trains.

NY A02114

Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations to negate or neutralize, in whole or in part, the pharmacological effects of an opioid in the human body.

NY S06613

Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations to negate or neutralize, in whole or in part, the pharmacological effects of an opioid in the human body.

NY A10193

Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.

NY S00821

Relates to availability of certain reports detailing sales of opioids in this state; excludes the name, address and DEA registration number of the entity to whom the opioid was sold from such publication.

NY A00996

Relates to availability of certain reports detailing sales of opioids in this state; excludes the name, address and DEA registration number of the entity to whom the opioid was sold from such publication.

NY A02506

Relates to the availability of agency records prior to or at an open meeting; removes the "to the extent practicable at least twenty-four hours" limitation from the requirement that agencies and departments shall make records available.

NY A04149

Requires public libraries to carry opioid antagonists; requires training for staff in the administration of opioid antagonists.

Similar Bills

No similar bills found.